
[Cancer Research 60, 321-327, January 15, 2000]
© 2000 American Association for Cancer Research
Experimental Therapeutics |
Radiation-induced Apoptosis of Endothelial Cells in the Murine Central Nervous System: Protection by Fibroblast Growth Factor and Sphingomyelinase Deficiency1
Louis A. Peña,
Zvi Fuks and
Richard N. Kolesnick2
Laboratory of Signal Transduction [L. A. P., R. N. K.] and Department of Radiation Oncology [L. A. P., Z. F.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021
 |
ABSTRACT
|
|---|
Injury to the central nervous system (CNS) by ionizing radiation may be
a consequence of damage to the vascular endothelium. Recent studies
showed that radiation-induced apoptosis of endothelial cells in
vitro and in the lung in vivo is mediated by the
lipid second messenger ceramide via activation of acid sphingomyelinase
(ASM). This apoptotic response to radiation can be inhibited by
basic fibroblast growth factor or by genetic mutation of ASM. In the
CNS, single-dose radiation has been shown to result in a 15% loss of
endothelial cells within 24 h, but whether or not this loss is
associated with apoptosis remains unknown. In the present studies,
dose- and time-dependent induction of apoptosis was observed in the
C57BL/6 mouse CNS. Apoptosis was quantified by terminal
deoxynucleotidyl transferase-mediated nick end labeling, and specific
endothelial apoptosis was determined by histochemical double labeling
with terminal deoxynucleotidyl transferase-mediated nick end labeling
and Lycopersicon esculentum lectin. Beginning at 4 h after single-dose radiation, apoptosis was ongoing for 24 h and
peaked at 12 h at an incidence of 0.71.4% of the total cells in
spinal cord sections. Up to 20% of the apoptotic cells were
endothelial. This effect was also seen in multiple regions of the brain
(medulla, pons, and hippocampus). A significant reduction of
radiation-induced apoptosis was observed after i.v. basic fibroblast
growth factor treatment (0.454.5 µg/mouse). Identical results were
noted in C3H/HeJ mice. Furthermore, irradiated ASM knockout mice
displayed as much as a 70% reduction in endothelial apoptosis. This
study demonstrates that ionizing radiation induces early endothelial
cell apoptosis throughout the CNS. These data are consistent with
recent evidence linking radiation-induced stress with ceramide and
suggest approaches to modify the apoptotic response in control of
radiation toxicity in the CNS.
 |
INTRODUCTION
|
|---|
Considerable effort has been made over the years to quantify the
tolerance of normal tissues to provide a baseline for therapeutic
irradiation at maximum biologically effective doses (1
, 2)
. Normal tissue injury by ionizing radiation differs depending
on the target organ and cell types. Acute or early reactions primarily
reflect the balance between the rates of cell killing by irradiation
and regeneration by surviving stem cells, whereas late reactions occur
when radiation depletes the tissue stem cell compartment, leading to
tissue necrosis, fibrosis, and organ dysfunction.
In the
CNS,3
there is a high degree of cellular heterogeneity, and both early and
late injuries occur (3
, 4)
. Whereas symptoms of acute and
subacute injury can be reversed to some extent with steroid medication,
the late forms of CNS injury are irreversible. The
TD5/5TD50/5 for
single-dose exposure are 1520 Gy and are similar for spinal cord
myelopathy, brain white matter necrosis (leukoencephalopathy), and
microvascular damage (1)
. The pathogenesis of myelin
degeneration and leukoencephalopathy is not fully understood. Whereas
one hypothesis suggests that oligodendrocyte injury mediates this
response, it is also possible that microvascular damage is a primary
culprit (5, 6, 7)
. Acute vascular changes within 24 h
after irradiation include increased endothelial cell swelling, vascular
permeability and edema, lymphocyte adhesion and infiltration, and
apoptosis (1
, 8)
. Late vascular effects occur weeks to
months after irradiation and include capillary collapse, thickening of
basement membranes, scarring and fibrosis, teleangiectasias, and a loss
of clonogenic capacity (1
, 8)
.
Despite the importance of radiation effects on the vascular endothelium
in the CNS, there are little current in vivo data on
endothelial cell death, and that which does exist is contradictory. A
study of irradiated rodent brain showed that up to 15% of endothelial
cells are lost within 24 h of irradiation (9)
, the
time frame in which apoptosis is most likely to occur. However, another
study failed to detect any endothelial cell apoptosis within the same
time frame (10
, 11)
. The present work was undertaken to
determine whether endothelial apo-ptosis occurs after CNS
irradiation in a rodent model and to determine the mechanism of this
response.
Recent studies have demonstrated that microvascular endothelial
apoptosis constitutes an early and critical element in radiation
pneumonitis and in the LPS-induced septic shock syndrome (12
, 13)
. The proapoptotic effects of radiation and of LPS were shown
to be mediated via the ASM and the generation of ceramide (13
, 14)
. Genetic mutations that inactivate ASM or treatment with
i.v. injections of bFGF abrogated ceramide generation and apoptosis.
The same mechanism of radiation-induced apoptosis via ceramide
generation was also observed in endothelial cells in vitro
(15)
, and the antiapo-ptotic action of bFGF
(16, 17, 18)
was shown to be mediated, at least in part, via
activation of the
isoform of PKC (17)
. A similar
interaction between radiation, ceramide, PKC, and apoptosis was
reported in the SQ-20B squamous carcinoma cell line, in which radiation
failed to elicit an apoptotic response unless PKC was blocked, leading
to increased apoptosis and clonogenic cell death in vitro
and in vivo (19
, 20)
. Radiation-induced
apoptosis in lymphoid cells is similarly associated with a balance
between ceramide and PKC activity, although in this system, Bcl-2 also
regulated ceramide- and radiation-induced apoptosis (21
, 22)
. Similarly, a loss of neutral sphingomyelinase has been
shown to confer radiation resistance in WEHI-231 and TF-1 lymphoid
cells, in which a reduction in both clonogenic death and apoptotic
death was associated with deficient ceramide production (19
, 20
, 23) . Zundel and Giaccia (24)
have shown that stress
signals apoptosis via ceramide-induced down-regulation of
phosphatidylinositol 3'-kinase and inhibition of the kinase Akt/PKB.
Inhibition of this pathway resulted in decreased phosphorylation of
Bad, a death effector in the Bcl-2 family. Signaling via the kinase
suppressor of Ras/mitogen-activated protein kinase pathway may
also cause the inactivation of Akt/PKB and the dephosphorylation of
Bad, although direct data on ionizing radiation as the apoptotic
stimulus for this pathway are currently lacking (25)
.
Hence, radiation-induced apo-ptotic signaling through ceramide
appears to involve multiple, coordinated pathways, and the apoptotic
outcome in vitro and in vivo depends on the
balance between the activities of pro- and antiapo-ptotic signaling
systems.
In this report, we examined in vivo the extent and kinetics
of CNS endothelial cell responses to radiation in the mature CNS of
mice. Dose- and time-dependent induction of apoptosis was observed in
the endothelium of the brain and spinal cord. A significant reduction
of this apoptotic response was observed after i.v. bFGF treatment or in
ASM KO mice. These radioprotective effects are consistent with an
emerging body of evidence linking radiation-induced stress responses in
endothelium with ceramide and suggest new approaches to modify the
apoptotic response in the control of radiation toxicity in the CNS.
 |
MATERIALS AND METHODS
|
|---|
Animals.
Male C57BL/6, C3H/HeJ, and 129/Sv mice were purchased from Taconic
(Germantown, NY) and housed in the Sloan-Kettering animal facility
until reaching a specific age for each experiment (16 weeks old, unless
stated otherwise). A colony of transgenic mice harboring a KO of the
ASM gene (ASM KO) was established at our animal facility, having
originally been obtained from Dr. Edward Schuchman (Department of
Genetics, Mount Sinai School of Medicine, New York, NY; Ref.
26
). These mice have a 129/Sv x C57BL/6
genetic background, therefore wild-type individuals of this cross were
used as controls in experiments involving ASM KO mice. It should be
noted that whereas ASM KO mice begin to exhibit Niemann-Pick
disease-like symptoms at approximately 20 weeks of age, experiments in
this study were carried out using ASM KO animals at 8 or 16 weeks of
age.
Irradiation.
Mice were lightly sedated with ketamine (0.1 mg/g), placed prone in a
137Cs irradiator (Shepherd Mark-I, Model 68), and
subjected to total body irradiation at a dose rate of 220 cGy/min. At
various time points, animals were euthanized and perfusion fixed
intracardially with fresh 4% paraformaldehyde in PBS. Brains and
spinal cords were dissected and post-fixed overnight and then placed in
an automated vacuum tissue processor for paraffin embedding over a 16-h
period. In some experiments, mice were also given i.v. injections of
recombinant bFGF or other cytokines (R&D Systems, Minneapolis, MN) in a
vehicle of 0.1% gelatin under metaphane anesthesia into the
retro-orbital plexus according to the following schedule: 5 min before
irradiation; immediately after irradiation; and 1 h after the
start of irradiation.
Apoptosis and Histochemical Analyses.
Noncontiguous 8-µm sections were mounted on slides, rehydrated, and
stained using the TUNEL method for detection of apoptosis in
situ, as described previously (16
, 27)
. Briefly,
slides were incubated with 3%
H2O2 in PBS for 5 min,
rinsed, and then incubated in TdT buffer [140 mM
cacodylate (pH 7.2), 30 mM Tris, and 1
mM CoCl2] for 15 min at
22°C. TdT reaction mixture was added [0.2 unit/µl TdT (Boehringer
Mannheim Roche; Indianapolis, IN), 2 nM
biotin-11-dUTP (Boehringer Mannheim Roche), 100
mM cacodylate (pH 7.0), 2.5
mM CoCl2, 0.1
mM DTT, and 0.05 mg/ml BSA] and incubated
for 30 min at 37°C. After blocking with 2% BSA and an incubation
with avidin-biotin peroxidase complexes (ABC kit; Vector Laboratories;
Burlingame, CA), the TUNEL reaction was visualized by chromogenic
staining with DAB (Sigma, St. Louis, MO). Slides were counterstained
with hematoxylin.
For immunohistochemical double labeling, TUNEL-stained sections were
transferred at room temperature to TBST buffer, followed by
blocking in 2% fetal bovine serum in TBST, three washes with PBS, and
an overnight incubation at 4°C with rhodamine-conjugated LEL (Sigma)
at a concentration of 25 µg/ml in PBS (28
, 29) . After
two washes with TBST and one 1-h wash with water, coverslips were
mounted with Permafluor (Shandon Lipshaw; Pittsburgh, PA). Two
alternative endothelial markers were used: (a) biotinylated
RCA-1 (Vector Laboratories) at 30 µg/ml (30, 31, 32, 33)
followed by incubation with rhodamine-conjugated avidin (Vector
Laboratories); or (b) antimouse CD31 monoclonal antibody
(PharMingen; San Diego, CA) at a 1:50 dilution in PBS (13
, 34
, 35)
followed by biotinylated antihamster IgG (PharMingen) at a
1:100 dilution [anti-CD31 was preceded by an antigen unmasking step of
20 min at 37°C with pepsin (Sigma; 60,000 units/ml) in water].
Stained slides were viewed with a Zeiss Axiophot-2 under light and/or
epifluorescence illumination with rhodamine filter sets.
Cell counts of TUNEL- and double-labeled TUNEL + LEL-stained
cells were counted manually in a single-blind fashion. Brown-stained
nuclei immediately at the edge of a tissue section were excluded from
cell counts to minimize false positives. Significant differences were
determined by one-tailed Students t test. For simple
counts of the total number of cells per spinal cord cross-section,
digital photomicroscopy images were acquired with a SPOT-32
charge-coupled device camera and imported into ImagePro Plus (Media
Cybernetics, Silver Spring, MD). After selecting a range of pixel color
values corresponding to blue-stained nuclei, a software function
generated cell count data, which were separately verified by comparing
to several manually counted sections.
 |
RESULTS
|
|---|
Whereas the radiation sensitivity of rodent tissue is age
dependent (36
, 37)
, initial experiments were carried out
to determine the age at which the apoptotic sensitivity of C57BL/6 mice
represents the sensitivity of adult CNS. Three strains of mice
(C57BL/6, C3H/HeJ, and 129/Sv) were irradiated at different ages with a
single dose of 50 Gy, and their spinal cords were harvested 12 h
after irradiation. A total of 1018 cross sections of spinal cord per
animal (representing cervical, thoracic, and lumbar regions without
bias) was stained using the TUNEL method and counterstained with
hematoxylin. The highest rate of apoptosis (1.1 ± 0.2%
per spinal cord section) was observed at the earliest time point tested
(8 weeks of age) and gradually decreased with time, reaching a plateau
at 16 weeks and beyond (0.5 ± 0.1% per spinal cord
section). Therefore, all experiments in this series were carried out
with mice at 16 weeks of age.
To further characterize the apoptotic response to radiation in the CNS,
time course and radiation dose-response studies were carried out. Fig. 1
depicts the dose response in spinal cord sections of duplicate mice at
several time points within a 24-h period. Previous work on the
radiation response of the mature rat CNS reported peak levels of
apoptosis in the subependymal zone of the brain that occurred at 68 h
after irradiation (38)
, and peak levels of apoptosis
occurred at 1012 h in the spinal cord (10)
. Our analysis
of the adult mouse CNS confirmed this time course. The apoptotic
response was dose dependent and peaked at 12 after irradiation (Fig. 1
). Similar results could be observed in various regions of the brain,
e.g., hippocampus and pons (data not shown). For subsequent
experiments, the dose of 50 Gy was preferred to increase the
statistical significance of cell counting of low frequency events. This
dose is likely to have relevance to biological phenomena because
previous studies showed that single-dose radiation of less than 10 Gy
produced no morphological changes in the CNS, whereas significant early
or latent effects were seen with doses between 20 and 40 Gy
(39)
. Furthermore, fractionated radiation in the range of
4560 Gy represents the lower tolerance threshold in humans
(40)
. Thus a 50 Gy single dose to the rodent CNS would be
expected to produce sublethal, subacute effects near the lower
tolerance threshold for the CNS (41)
.

View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 1. Time course and dose response. Four-month-old mice were
irradiated with whole body -radiation at various doses, and the CNS
was harvested at various time points, as indicated. Paraffin-embedded
cross sections of the spinal cord were stained using the TUNEL method,
and the number of positively stained nuclei was counted
(n = 2 mice, 812 sections/mouse). SE
was <10%.
|
|
In the experiments quoted above, the absolute numbers of apoptotic
cells, rather then the percentage, were used to quantify the response
to radiation. However, it should be noted that previous studies
reported that whereas the numbers of neurons may vary considerably
among different spinal cord levels, the total numbers of cells,
including neurons, glial cells, oligodendrocytes, and endothelial
cells, remained somewhat constant (42
, 43)
. The present
studies confirmed these findings. Image analysis of hematoxylin-stained
spinal cord sections of 16 week old C57/BL6 mice revealed that the
total number of cells was consistent across the total length of the
cord, averaging 1667 ± 318 cells per cross section. It
should also be noted that no significant variations between individual
mice of the same or different strains were discerned (data not shown).
For example, the average cross section of 16-week-old ASM KO mice had a
mean of 1600 ± 294 cells. These data indicate that in
evaluating apoptotic responses to radiation in the spinal cord, it is
legitimate to report the absolute number of apoptotic cells rather than
a percentage of apoptotic cells per section. Furthermore, in
irradiated spinal cord specimens, the total number of apoptotic cells
[range, 0.71.4%, in agreement with the studies of Li et
al. on rat spinal cord (10
, 11)
] was also found to
be constant across different cord levels and across strains (see
controls in Fig. 3B
).

View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 3. A, radioprotection by FGFs. Retro-orbital
i.v. injections of aFGF or bFGF reduced apoptosis assessed by TUNEL
staining in the spinal cord at 12 h after irradiation with 50 Gy
(n = 2 mice; 1620 sections/mouse). FGFs
were administered in three equivalent doses totaling 4.5 or 0.45 µg
per 2630-g mouse. [All treated animals were significantly different
from sham-injected controls (P < 0.001).] B, FGF radioprotection and mouse strain
differences. bFGF was administered via i.v. injection to 16-week-old
C3H or BL6 mice, which were then irradiated with 50 Gy
(n = 2 mice) and harvested after 12 h, and TUNEL-stained cells were counted to reveal the total number of
cells undergoing apoptosis in spinal cord sections. Apoptosis in
treated animals was significantly different from that in sham-injected
controls (P < 0.001); no significant
difference was seen between strains (P = 0.08).
|
|
To identify which specific cell types were undergoing apoptosis, we
used double staining procedures with cell phenotype-specific reagents.
In this study, we describe results pertaining to endothelial cells.
Widely used antibodies directed against specific adhesion molecules
[e.g., PECAM-1 (CD31) and E-selectin (CD62e)] are
effective in specifically identifying endothelial cells in several
tissues, but not in the CNS, where these cell surface markers are
down-regulated coincident with the development of the blood brain
barrier (34
, 35) . Consistent with this observation, we
found that staining with an antibody against CD31 failed to
stain microvessel endothelium within the brain (data not shown). In
contrast, lectin staining, such as staining with LEL and RCA-1, has
been shown to reliably label endothelium in the CNS (28, 29, 30, 31, 32, 33
, 44)
. The LEL staining method used in the present study is a
single-step procedure and preferentially enhances endothelial staining
while reducing microglial staining. Fig. 2
shows double labeling of cells with LEL and TUNEL at high magnification
(x1000). An endothelial cell exhibiting intensely fluorescent LEL
staining (Fig. 2A
, top) is the same cell whose
apoptotic nucleus is TUNEL positive (Fig. 2A
, middle). These
images were digitally superimposed to demonstrate the colocalization of
these two markers (Fig. 2A
, bottom). Lectin stains can also
label microglia (30, 31, 32, 33)
, the resident tissue macrophages
of the CNS. The distinct morphology of microglia is demonstrated in
Fig. 2B
, whose significantly weaker staining has been
enhanced in this exposure only for the purposes of reproduction for
publication. The double stain studies revealed that the fraction of
endothelial cells in the total population of cells undergoing apoptosis
at 12 h after exposure to 50 Gy was 1620%. The majority of
apoptotic cells that were nonendothelial are likely to be glial, based
on morphological criteria, in agreement with data reported by Li
et al. (10)
.

View larger version (59K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 2. A, histochemical, fluorescent, double
labeling of endothelial cells undergoing apoptosis in the irradiated
CNS. Magnification, x1000. Top, LEL conjugated to
rhodamine (LEL-TRITC) brightly stains endothelial cells
in paraffin sections of the CNS. Intense endothelial staining is
evident at all levels of magnification. Middle,
apoptosis in the same section is revealed by the TUNEL reaction using
the brown chromogen DAB (TUNEL-DAB).
Bottom, composite image showing specific, overlapping
double staining in one endothelial cell undergoing apoptosis. The
quantification of endothelial cell apoptosis is shown in Tables 1
and 3
. B, microglial staining. The very different and easily
recognized multipolar morphology of microglial cells is also revealed
with LEL staining. However, with this method, microglial staining is
very faint and is observable only at the highest magnification
(x1000). This image was overexposed and contrast-adjusted for the
purpose of publication.
|
|
To explore the mechanism of radiation-induced apoptosis in the CNS
endothelium of the adult mouse, we studied the effects of i.v.
injection of aFGF and bFGF. In previous studies, we demonstrated that
bFGF serves as an antiapoptotic survival factor for endothelial cells
irradiated in vitro and in a lung model in vivo
(12
, 16 , 17
, 45)
. The effect of FGF in the murine CNS was
first assessed by treating animals with three equal doses of aFGF or
bFGF, which were administered i.v. immediately before and after, and at
1 h after 50 Gy of irradiation (total dose delivered, 0.454.5
µg/mouse). TUNEL-positive apoptotic cells were counted in CNS
specimens obtained 12 h after irradiation. Both bFGF and aFGF
reduced the total level of apoptosis by approximately 50% (Fig. 3A
). All treated animals were significantly different from
sham-injected controls (P < 0.001). Similar
significant reductions in apoptosis were measured in two strains of
mice tested, C3H/HeJ and C57BL/6 (P < 0.001
each; Fig. 3B
). Differences between strains were not
significant (P = 0.08). To explore whether
the antiapoptotic effect of FGF was specific to the endothelial cell
subpopulation of the irradiated CNS, the double labeling technique with
TUNEL and LEL was used. Table 1
shows that similar to the effect of bFGF on the total cell population,
treatment with bFGF resulted in an approximately 50% reduction in
endothelial cell apoptosis. These ratios remained approximately the
same in separate experiments with varying doses of radiation (1, 5, 10,
and 20 Gy) and a constant dose of bFGF (data not shown). These data
indicated that whereas FGF may protect more than one of the
subpopulations of CNS cells, endothelial cells in vivo are
indeed definitely radioprotected, as has been observed previously
in vitro and in other organs in vivo (12
, 16
, 46, 47, 48, 49, 50)
.
View this table:
[in this window]
[in a new window]
|
Table 1 Apoptosis in endothelial cell subpopulation in the spinal cord of
bFGF-treated mice
Spinal cord sections of mice that were irradiated and received sham or
bFGF injections (4.5 µg/mouse) were harvested at 12 h
(n = 3 mice, 1620 sections each) and double
stained with LEL-TRITC and TUNEL-DAB to specifically label apoptotic
endothelial cells (see "Materials and Methods"). Double-positive
cells were counted, and the means were subjected to paired t
tests for statistical significance.
|
|
Previous studies of cultured endothelial cells showed that bFGF blocks
radiation-induced apoptosis (17
, 18
, 45)
, likely via
inhibition of ASM-mediated hydrolytic degradation of membrane
sphingomyelin (14
, 15)
. Furthermore, ASM KO mice that have
a defect in ceramide generation (26)
exhibit resistance to
the apoptotic effects of radiation in vivo
(14)
. A comparison of irradiated ASM KO mice with
wild-type controls in the present studies showed that the total number
of apoptotic cells was decreased 5075% in the spinal cords of ASM KO
mice (Fig. 4
). Quantitative differences between wild-type and ASM KO mice were also
evident in different regions of the brain, such as the hippocampus
(Fig. 5
) midbrain, and hindbrain (data not shown). Differences between
wild-type and ASM KO mice were significant (Table 2)
. TUNEL/LEL double staining to identify the endothelial cell
subpopulation showed a 3-fold difference between the wild-type and KO
strains (Table 3)
. These data suggest that the effect of radiation to induce apoptosis
in the cells of the CNS microvasculature is mediated via the
ASM/ceramide pathway.

View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 4. Reduced apoptosis in spinal cord sections of
ceramide-deficient ASM KO mice. ASM KO and wild-type mice
(C57/BL6 x SV129/J) were irradiated with 25 or 50 Gy
and harvested after 12 h, and TUNEL-positive cells were counted.
Apoptosis in irradiated ASM KO animals was significantly different from
that in paired, irradiated controls (P < 0.01).
|
|

View larger version (131K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 5. Reduced apoptosis in hippocampal sections of
ceramide-deficient ASM KO mice. In these panels depicting the
hippocampus (x100; counterstain, hematoxylin), arrows
have been placed beside TUNEL-positive nuclei that are not apparent at
this low-power magnification. Identification of TUNEL-stained cells was
done at x400 and x1000. See Table 2
.
|
|
View this table:
[in this window]
[in a new window]
|
Table 2 Total apoptosis in brain regions of wild-type and ASM KO mice
Wild-type (129Sv x C57BL/6) and ASM KO mice were
irradiated with 50 Gy, and tissues were harvested at 12 h. Total
number of TUNEL-positive, apoptotic cells was counted in different,
matched regions of the brain (n = 2 mice,
816 sections). Paired, two-tailed t tests were computed to
estimate statistical significance.
|
|
View this table:
[in this window]
[in a new window]
|
Table 3 Apoptosis of endothelial cell subpopulation in ceramide
generation-impaired ASM KO mice
Counts of apoptotic endothelial cells in spinal cord sections of
wild-type (wt) or ASM KO mice, as described above.
|
|
 |
DISCUSSION
|
|---|
In the present studies, we demonstrated that radiation induces an
apoptotic response in the CNS at times and dose ranges relevant to
acute radiation toxicity. After single-dose irradiation, there was
evidence of ongoing apoptosis between 4 and 24 h after exposure,
which peaked at 12 h. The peak incidence of apoptosis was
0.71.4% of the cells in spinal cord sections. These time frames and
the incidence are consistent with the observation of Li et
al. (11)
, who showed in rat spinal cord that
apoptosis occurred throughout the first 24 h after single-dose
irradiation and peaked at 12 h at an incidence of 3%.
Furthermore, that study also demonstrated that this level of ongoing
apoptosis translated into an 18% loss of spinal cord cells by 24 h. This magnitude of apoptosis is likely to have functional
consequences for the generation of radiation toxicity.
Our present studies also showed that 1620% of the cells undergoing
apoptosis were endothelial cells, whereas the rest involved glial
subpopulations of the CNS parenchyma. It has been estimated that the
number of endothelial cells in the adult mouse spinal cord is
2.50 x 106 of a total population
of 13.08 x 106 cells
(42)
, representing approximately 20% of the total. Hence,
the incidence of endothelial apoptosis was proportional to the
endothelial cell fraction of the total CNS cell population. Whereas the
peak incidence of endothelial apoptosis appears to be low, the overall
apoptotic response over the first 24-h period after radiation may be
considerable and significant for the generation of tissue responses.
Consistent with this notion is the study by Ljubimova et al.
(9)
, which reported that 15% of the CNS endothelium is
lost by 24 h after exposure to 25100 Gy.
The fact that both endothelial cells and other parenchymal CNS cells
undergo concomitant apoptosis leaves open the question of which
component is critical to the evolution of acute radiation toxicity in
the CNS. In previous studies, we demonstrated that microvascular
endothelial apoptosis was the primary and critical response in the
generation of tissue damage by radiation and other stresses. The
microvascular endothelium was the earliest tissue component to undergo
apoptosis in the irradiated lung of C3H/HeJ mice (12
, 16
, 17)
and in the small intestine, lung, and fat tissue of C57BL/6
mice during experimental septic shock (13)
. The critical
role of this response in the evolution of tissue damage was suggested
by the fact that both endothelial apoptosis and the eventual tissue
damage were abrogated by i.v. bFGF therapy. Furthermore, ASM KO mice
were found to be refractory to lung irradiation- and LPS-induced
microvascular endothelial apoptosis, tissue damage, and animal death in
response to these stresses (13
, 14)
. The present studies
showed that in the CNS, both FGF and ASM deficiency reduced
radiation-induced apoptosis in the endothelial compartment. However,
because endothelial apoptosis and nonendothelial apoptosis occur
simultaneously, whether apoptotic damage to the microvasculature is
critical to the pathogenesis of acute radiation damage to the adult
mouse CNS remains unclear. The finding that bFGF and ASM deficiency
reduces the apoptotic response to radiation provides a possible
approach to further explore whether this acute apoptosis, over the long
term, has relevance to early or late CNS injury.
Whereas the present studies provided evidence for radiation-induced
endothelial apoptosis, prior investigations by Li et al.
(10
, 11)
failed to detect endothelial cell apoptosis in
the irradiated CNS. Differences in the histochemical assays to identify
the cell types undergoing apoptosis may have accounted for this
apparent discrepancy. Whereas we used the TUNEL/LEL double labeling
technique to distinguish between endothelial and nonendothelial
apoptosis, Li et al. used single-agent staining with either
the Leu-7 antibody, anti-GFAP antibody, or the RCA-1 lectin (10
, 11)
. In the Li et al. studies, apoptotic cells were
stained only by the Leu-7 antibody, leading to the conclusion that only
oligodendrocytes undergo apoptosis in response to CNS irradiation.
Leu-7 labels the myelin-associated glycoprotein of oligodendrocytes and
oligodendrogliomas because the carbohydrate residues of this protein
contain the HNK-1 epitope (51, 52, 53)
. However, the
HNK-1 epitope also occurs in a class of glycolipids known as
sulfoglucuronosyl paraglobosides, which are present in brain
microvascular endothelial cells (54, 55, 56)
. These
sulfo-glycolipids are thought to mediate activated lymphocyte
attachment to endothelial cells and subsequent infiltration into the
parenchyma of the CNS. The HNK-1 epitope has also been found on neurons
(57
, 58)
and immature astrocytes (52)
, in
addition to the population of natural killer cells and
T-lymphocytes from which it was originally described (59)
.
Hence, Leu-7/HNK-1 staining appears to lack specificity and may stain
CNS endothelial cells in addition to oligodendrocytes.
The present observations are also consistent with a large body of data
demonstrating survival effects for FGF on several CNS cell types
in vivo after a variety of injuries or stresses (for review,
see Refs. 60, 61, 62, 63, 64, 65, 66
). Furthermore, FGF has been shown to
exert radioprotective effects in several non-CNS tissue systems
in vivo. Ding et al. (46, 47, 48)
and
Okunieff et al. (49
, 50)
have reported that in
C3H mice, both bFGF and, to a lesser extent, aFGF exhibit
radioprotective effects in lymphoid cells and intestinal crypt cells,
and our group has previously observed protection by bFGF in the lung
(12
, 13 , 16)
. Although the mechanisms involved in the
radioprotective effects of FGF are not fully known, evidence suggests
that PKC, which serves as the effector system mediating the
radioprotective effect of bFGF in primary cultures of bovine
endothelium, may act by blocking sphingomyelin hydrolysis to ceramide
(15
, 17)
. Oligodendrocytes and other glial cells
(61
, 62
, 67
, 68)
express FGF receptors, and
oligodendrocyte apoptosis has been linked to ceramide generation in
some instances (for a review, see Ref. 69
). Whether bFGF
protects glial elements from radiation-induced apoptosis directly or
indirectly by preserving microvessels cannot be answered by the present
data. Derivatized forms of bFGF, either biotinylated or radiolabeled
with 111In or 125I, failed
to gain access to the parenchyma of the brain and remained in the
intima of capillaries (16
, 70)
, and lacked protective
effects, whereas metabolically labeled
[14C]bFGF freely crossed the blood brain
barrier and exerted protective effects (71)
. Further
experimentation is necessary to determine whether FGF is effective in
abrogating the deleterious tissue effects of radiation on the CNS and
whether it is mediated via an antiapoptotic effect on oligodendrocytes,
endothelial cells, or both. The study of ASM KO mice may be useful for
this distinction.
ACKNOWLEDGMENTS
We thank M. Sockie Jiao and Desiree A. Ehleiter for outstanding
technical support and Drs. Mark Garzotto and Adriana Haimovitz-Friedman
for scientific advice.
 |
FOOTNOTES
|
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by NIH/National Cancer Institute
Research Career Development Award K01-CA-76483 (to L. A. P.) and NIH
Grants CA-52462 (to Z. F.) and CA-42385 (to R. N. K.). 
2 To whom requests for reprints should be
addressed, at Laboratory of Signal Transduction, Memorial
Sloan-Kettering Cancer Center, 1275 York Avenue, Box 254, New York, NY
10021. Phone: (212) 639-8573; Fax: (212) 639-2767; E-mail: r-kolesnick{at}ski.mskcc.org 
3 The abbreviations used are: CNS, central nervous
system; ASM, acid sphingomyelinase; FGF, fibroblast growth factor;
bFGF, basic FGF; TdT, terminal deoxynucleotidyl transferase; TUNEL,
TdT-mediated nick end labeling; LPS, lipopolysaccharide; PKC, protein
kinase C; KO, knockout; TBST, 50 mM Tris (pH 7.5), 150
mM NaCl, and 0.1% Triton X-100; LEL, Lycopersicon
esculentum lectin; RCA-1, Ricinus communis
agglutinin 1; aFGF, acidic FGF; DAB, 3,3'-diaminobenzidine
tetrachloride. 
Received 7/27/99.
Accepted 11/15/99.
 |
REFERENCES
|
|---|
-
Vaeth, J. M., and Meyer, J. L. Radiation Tolerance of Normal Tissues, Vol. 23. Basel, Switzerland: Karger, 1989.
-
Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J. E., Shank B., Solin L. J., Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys., 21: 109-122, 1991.[Medline]
-
Sheline G. E., Wara W. M., Smith V. Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys., 6: 1215-1228, 1980.[Medline]
-
Ang K. K., Stephens L. C. Prevention and management of radiation myelopathy. Oncology (Basel), 8: 71-82, 1994.[Medline]
-
Myers R., Rogers M. A., Hornsey S. A reappraisal of the roles of glial and vascular elements in the development of white matter necrosis in irradiated rat spinal cord. Br. J. Cancer, 53(Suppl.7): 221-223, 1986.
-
van der Kogel A. J. Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br. J. Cancer, 53(Suppl.7): 207-217, 1986.
-
van der Kogel, A. J., Kleiboer, B. J., Verhagen, I., Morris, G. M., Hopewell, J. W., and Coderre, J. A. White matter necrosis of the spinal cord: studies on glial progenitor survival and selective vascular irradiation. In: U. Hagen, D. Harder, H. Jung, and C. Streffer (eds.), Radiation Research 18951995, Congress Proceedings, Vol. 2, pp. 769772. Wurzburg, Germany: International Congress of Radiation Research Society, 1995.
-
Baker D. G., Krochak R. J. The response of the microvascular system to radiation: a review. Cancer Investig., 7: 287-294, 1989.[Medline]
-
Ljubimova N. V., Levitman M. K., Plotnikova E. D., Eidus L. Endothelial cell population dynamics in rat brain after local irradiation. Br. J. Radiol., 64: 934-940, 1991.[Abstract/Free Full Text]
-
Li Y. Q., Guo Y. P., Jay V., Stewart P. A., Wong C. S. Time course of radiation-induced apoptosis in the adult rat spinal cord. Radiother. Oncol., 39: 35-42, 1996.[Medline]
-
Li Y. Q., Jay V., Wong C. S. Oligodendrocytes in the adult rat spinal cord undergo radiation-induced apoptosis. Cancer Res., 56: 5417-5422, 1996.[Abstract/Free Full Text]
-
Fuks Z., Alfieri A., Haimovitz-Friedman A., Seddon A., Cordon-Cardo C. Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo. Cancer J. Sci. Am., 1: 62-72, 1995.[Medline]
-
Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., Edwards C. K., III, Schuchman E. H., Fuks Z., Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med., 186: 1831-1841, 1997.[Abstract/Free Full Text]
-
Santana P., Peña L. A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchman E. H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell, 86: 189-199, 1996.[Medline]
-
Haimovitz-Friedman A., Kan C. C., Ehleiter D., Persaud R. S., McLoughlin M., Fuks Z., Kolesnick R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525-535, 1994.[Abstract/Free Full Text]
-
Fuks Z., Persaud R. S., Alfieri A., McLoughlin M., Ehleiter D., Schwartz J. L., Seddon A. P., Cordon-Cardo C., Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res., 54: 2582-2590, 1994.[Abstract/Free Full Text]
-
Haimovitz-Friedman A., Balaban N., McLoughlin M., Ehleiter D., Michaeli J., Vlodavsky I., Fuks Z. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res., 54: 2591-2597, 1994.[Abstract/Free Full Text]
-
Langley R. E., Bump E. A., Quartuccio S. G., Medeiros D., Braunhut S. J. Radiation-induced apoptosis in microvascular endothelial cells. Br. J. Cancer, 75: 666-672, 1997.[Medline]
-
Quintans J., Kilkus J., McShan C. L., Gottschalk A. R., Dawson G. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem. Biophys. Res. Commun., 202: 710-714, 1994.[Medline]
-
Chmura S. J., Nodzenski E., Beckett M. A., Kufe D. W., Quintans J., Weichselbaum R. R. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res., 57: 1270-1275, 1997.[Abstract/Free Full Text]
-
Chen M., Quintans J., Fuks Z., Thompson C., Kufe D. W., Weichselbaum R. R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor
, and ceramide. Cancer Res., 55: 991-994, 1995.[Abstract/Free Full Text]
-
Kelly M. L., Tang Y., Rosensweig N., Clejan S., Beckman B. S. Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase C
. Blood, 92: 416-424, 1998.[Abstract/Free Full Text]
-
Bruno A. P., Laurent G., Averbeck D., Demur C., Bonnet J., Bettaieb A., Levade T., Jaffrezou J. P. Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ., 5: 172-182, 1998.[Medline]
-
Zundel W., Giaccia A. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev., 12: 1941-1946, 1998.[Abstract/Free Full Text]
-
Basu S., Bayoumy S., Zhang Y., Lozano J., Kolesnick R. BAD enables ceramide to signal apoptosis via ras and raf-1. J. Biol. Chem., 273: 30419-30426, 1998.[Abstract/Free Full Text]
-
Horinouchi K., Erlich S., Perl D. P., Ferlinz K., Bisgaier C. L., Sandhoff K., Desnick R. J., Stewart C. L., Schuchman E. H. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet., 10: 288-293, 1995.[Medline]
-
Sanders E. J. Methods for detecting apoptotic cells in tissues. Histol. Histopathol., 12: 1169-1177, 1997.[Medline]
-
Acarin L., Vela J. M., Gonzalez B., Castellano B. Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J. Histochem. Cytochem., 42: 1033-1041, 1994.[Abstract]
-
Fakla I., Hever A., Molnar J., Fischer J. Tomato lectin labels the 180 kD glycoform of P-glycoprotein in rat brain capillary endothelia and mdr tumor cells. Anticancer Res., 18: 3107-3111, 1998.[Medline]
-
Seitz R. J., Deckert M., Wechsler W. Vascularization of syngenic intracerebral RG2 and F98 rat transplantation tumors. A histochemical and morphometric study by use of Ricinus communis agglutinin I. Acta Neuropathol., 76: 599-605, 1988.[Medline]
-
Wang X. C., Kochi N., Tani E., Kaba K., Matsumoto T., Shindo H. Lectin histochemistry of human gliomas. Acta Neuropathol., 79: 176-182, 1989.[Medline]
-
Szumanska G. Lectin histochemistry in the rats brain in experimental postresuscitation syndrome: early and late changes. Folia Neuropathol., 34: 76-86, 1996.[Medline]
-
Nico B., Quondamatteo F., Ribatti D., Bertossi M., Russo G., Herken R., Roncali L. Ultrastructural localization of lectin binding sites in the developing brain microvasculature. Anat. Embryol., 197: 305-315, 1998.[Medline]
-
Williams K. C., Zhao R. W., Ueno K., Hickey W. F. PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat. J. Neurosci. Res., 45: 747-757, 1996.[Medline]
-
Lossinsky A. S., Wisniewski H. M., Dambska M., Mossakowski M. J. Ultrastructural studies of PECAM-1/CD31 expression in the developing mouse blood-brain barrier with the application of a pre-embedding technique. Folia Neuropathol., 35: 163-170, 1997.[Medline]
-
Grahn D. Acute radiation response of mice from a cross between radiosensitive and radioresistant strains. Genetics, 43: 835-843, 1958.[Free Full Text]
-
Roderick T. H. The response of twenty-seven inbred strains of mice to daily doses of whole-body X-irradiation. Radiat. Res., 20: 631-639, 1963.
-
Shinohara C., Gobbel G. T., Lamborn K. R., Tada E., Fike J. R. Apoptosis in the subependyma of young adult rats after single and fractionated doses of X-rays. Cancer Res., 57: 2694-2702, 1997.[Abstract/Free Full Text]
-
Hopewell J. W., Wright E. A. The nature of latent cerebral irradiation damage and its modification by hypertension. Br. J. Radiol., 43: 161-167, 1970.[Abstract/Free Full Text]
-
Schultheiss T. E., Kun L. E., Ang K. K., Stephens L. C. Radiation response of the central nervous system. Int. J. Radiat. Oncol. Biol. Phys., 31: 1093-1112, 1995.[Medline]
-
van der Kogel, A. J. Small animal models of radiation injury to the CNS. In: P. H. Gutin, S. A. Leibel, and G. E. Sheline (eds.), Radiation Injury to the Nervous System. New York: Raven Press, 1991.
-
Bjugn R. The use of the optical disector to estimate the number of neurons, glial, and endothelial cells in the spinal cord of the mouse, with a comparative note on the rat spinal cord. Brain Res., 627: 25-33, 1993.[Medline]
-
Bjugn R., Gundersen H. J. Estimate of the total number of neurons and glial and endothelial cells in the rat spinal cord by means of the optical disector. J. Comp. Neurol., 328: 406-414, 1993.[Medline]
-
Bankston P. W., Porter G. A., Milici A. J., Palade G. E. Differential and specific labeling of epithelial and vascular endothelial cells of the rat lung by Lycopersicon esculentum and Griffonia simplicifolia I lectins. Eur. J. Cell Biol., 54: 187-195, 1991.[Medline]
-
Haimovitz-Friedman A., Vlodavsky I., Chaudhuri A., Witte L., Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res., 51: 2552-2558, 1991.[Abstract/Free Full Text]
-
Ding I., Huang K., Snyder M. L., Cook J., Zhang L., Wersto N., Okunieff P. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors. J. Natl. Cancer Inst., 88: 1399-1404, 1996.[Abstract/Free Full Text]
-
Ding I., Huang K., Wang X., Greig J. R., Miller R. W., Okunieff P. Radioprotection of hematopoietic tissue by fibroblast growth factors in fractionated radiation experiments. Acta Oncol., 36: 337-340, 1997.[Medline]
-
Ding I., Wu T., Matsubara H., Magae J., Shou M., Cook J., Okunieff P. Acidic fibroblast growth factor (FGF1) increases survival and haematopoietic recovery in total body irradiated C3H/HeNCr mice. Cytokine, 9: 59-65, 1997.[Medline]
-
Okunieff P., Wu T., Huang K., Ding I. Differential radioprotection of three mouse strains by basic or acidic fibroblast growth factor. Br. J. Cancer, 74(Suppl.27): S105-S108, 1996.
-
Okunieff P., Mester M., Wang J., Maddox T., Gong X., Tang D., Coffee M., Ding I. In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat. Res., 150: 204-211, 1998.[Medline]
-
McGarry R. C., Helfand S. L., Quarles R. H., Roder J. C. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature (Lond.), 306: 376-378, 1983.[Medline]
-
McGarry R. C., Riopelle R. J., Frail D. E., Edwards A. M., Braun P. E., Roder J. C. The characterization and cellular distribution of a family of antigens related to myelin associated glycoprotein in the developing nervous system. J. Neuroimmunol., 10: 101-114, 1985.[Medline]
-
Nakagawa Y., Perentes E., Rubinstein L. J. Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers. Acta Neuropathol., 72: 15-22, 1986.[Medline]
-
Needham L. K., Schnaar R. L. The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc. Natl. Acad. Sci. USA, 90: 1359-1363, 1993.[Abstract/Free Full Text]
-
Kanda T., Yamawaki M., Ariga T., Yu R. K. Interleukin 1ß up-regulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells. Proc. Natl. Acad. Sci. USA, 92: 7897-7901, 1995.[Abstract/Free Full Text]
-
Yu R. K., Ariga T. The role of glycosphingolipids in neurological disorders. Mechanisms of immune action. Ann. NY Acad. Sci., 845: 285-306, 1998.[Medline]
-
Reifenberger G., Mai J. K., Krajewski S., Wechsler W. Distribution of anti-Leu-7, anti-Leu-11a and anti-Leu-M1 immunoreactivity in the brain of the adult rat. Cell Tissue Res., 248: 305-313, 1987.[Medline]
-
Kalcheim C., Gendreau M. Brain-derived neurotrophic factor stimulates survival and neuronal differentiation in cultured avian neural crest. Brain Res., 469: 79-86, 1988.[Medline]
-
Lanier L. L., Le A. M., Phillips J. H., Warner N. L., Babcock G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol., 131: 1789-1796, 1983.[Abstract]
-
Oomura Y., Sasaki K., Suzuki K., Muto T., Li A. J., Ogita Z., Hanai K., Tooyama I., Kimura H., Yanaihara N. A new brain glucosensor and its physiological significance. Am. J. Clin. Nutr., 55: 278S-282S, 1992.[Abstract/Free Full Text]
-
Eckenstein F. P., Andersson C., Kuzis K., Woodward W. R. Distribution of acidic and basic fibroblast growth factors in the mature, injured and developing rat nervous system. Prog. Brain Res., 103: 55-64, 1994.[Medline]
-
Mocchetti I., Wrathall J. R. Neurotrophic factors in central nervous system trauma. J. Neurotrauma, 12: 853-870, 1995.[Medline]
-
Grothe C., Wewetzer K. Fibroblast growth factor and its implications for developing and regenerating neurons. Int. J. Dev. Biol., 40: 403-410, 1996.[Medline]
-
Bikfalvi A., Klein S., Pintucci G., Rifkin D. B. Biological roles of fibroblast growth factor-2. Endocr. Rev., 18: 26-45, 1997.[Abstract/Free Full Text]
-
Cuevas P., Gimenez-Gallego G. Role of fibroblast growth factors in neural trauma. Neurol. Res., 19: 254-256, 1997.[Medline]
-
Cuevas P. Therapeutic prospects for fibroblast growth factor treatment of brain ischemia. Neurol. Res., 19: 355-356, 1997.[Medline]
-
Walicke P. A. Novel neurotrophic factors, receptors, and oncogenes. Annu. Rev. Neurosci., 12: 103-126, 1989.[Medline]
-
Weisenhorn D. M., Roback J., Young A. N., Wainer B. H. Cellular aspects of trophic actions in the nervous system. Int. Rev. Cytol., 189: 177-265, 1999.[Medline]
-
Mathias S., Peña L. A., Kolesnick R. N. Signal transduction of stress via ceramide. Biochem. J., 335: 465-480, 1998.
-
Fisher M., Meadows M. E., Do T., Weise J., Trubetskoy V., Charette M., Finklestein S. P. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 15: 953-959, 1995.[Medline]
-
Cuevas P., Carceller F., Munoz-Willery I., Gimenez-Gallego G. Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippocampal neurons against ischemia-reperfusion injury. Surg. Neurol., 49: 77-84, 1998.[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
M.-L. Alvarez Gonzalez, F. Frankenne, C. Galant, E. Marbaix, J.-M. Foidart, M. Nisolle, and A. Beliard
Mixed origin of neovascularization of human endometrial grafts in immunodeficient mouse models
Hum. Reprod.,
September 1, 2009;
24(9):
2217 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Cao, C. I. Tsien, P. C. Sundgren, V. Nagesh, D. Normolle, H. Buchtel, L. Junck, and T. S. Lawrence
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for Prediction of Radiation-Induced Neurocognitive Dysfunction
Clin. Cancer Res.,
March 1, 2009;
15(5):
1747 - 1754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Smith and E. H. Schuchman
The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases
FASEB J,
October 1, 2008;
22(10):
3419 - 3431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bonnaud, C. Niaudet, G. Pottier, M.-H. Gaugler, J. Millour, J. Barbet, L. Sabatier, and F. Paris
Sphingosine-1-Phosphate Protects Proliferating Endothelial Cells from Ceramide-Induced Apoptosis but not from DNA Damage-Induced Mitotic Death
Cancer Res.,
February 15, 2007;
67(4):
1803 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. W. Huang, J. Yang, A. F. Dragovic, H. Zhang, T. S. Lawrence, and M. Zhang
Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis.
Clin. Cancer Res.,
May 1, 2006;
12(9):
2849 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gulbins and P. L. Li
Physiological and pathophysiological aspects of ceramide
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2006;
290(1):
R11 - R26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Stover, A. Sharma, G. P. Robertson, and M. Kester
Systemic Delivery of Liposomal Short-Chain Ceramide Limits Solid Tumor Growth in Murine Models of Breast Adenocarcinoma
Clin. Cancer Res.,
May 1, 2005;
11(9):
3465 - 3474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otala, M. O. Pentikainen, T. Matikainen, L. Suomalainen, J. K. Hakala, G. I. Perez, M. Tenhunen, K. Erkkila, P. Kovanen, M. Parvinen, et al.
Effects of Acid Sphingomyelinase Deficiency on Male Germ Cell Development and Programmed Cell Death
Biol Reprod,
January 1, 2005;
72(1):
86 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Akashi
Role of infection and bleeding in multiple organ involvement and failure
Br. J. Radiol.,
January 1, 2005;
Supplement_27(1):
69 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M-H Gaugler
A unifying system: does the vascular endothelium have a role to play in multi-organ failure following radiation exposure?
Br. J. Radiol.,
January 1, 2005;
Supplement 27(1):
100 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Wong and A. J. Van der Kogel
MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTION
Mol. Interv.,
October 1, 2004;
4(5):
273 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Woywodt, J. Scheer, L. Hambach, S. Buchholz, A. Ganser, H. Haller, B. Hertenstein, and M. Haubitz
Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation
Blood,
May 1, 2004;
103(9):
3603 - 3605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Q. Li, P. Chen, A. Haimovitz-Friedman, R. M. Reilly, and C. S. Wong
Endothelial Apoptosis Initiates Acute Blood-Brain Barrier Disruption after Ionizing Radiation
Cancer Res.,
September 15, 2003;
63(18):
5950 - 5956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Abdollahi, K. E. Lipson, X. Han, R. Krempien, T. Trinh, K. J. Weber, P. Hahnfeldt, L. Hlatky, J. Debus, A. R. Howlett, et al.
SU5416 and SU6668 Attenuate the Angiogenic Effects of Radiation-induced Tumor Cell Growth Factor Production and Amplify the Direct Anti-endothelial Action of Radiation in Vitro
Cancer Res.,
July 1, 2003;
63(13):
3755 - 3763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Wachsberger, R. Burd, and A. P. Dicker
Tumor Response to Ionizing Radiation Combined with Antiangiogenesis or Vascular Targeting Agents: Exploring Mechanisms of Interaction
Clin. Cancer Res.,
June 1, 2003;
9(6):
1957 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maddens, A. Charruyer, I. Plo, P. Dubreuil, S. Berger, B. Salles, G. Laurent, and J.-P. Jaffrezou
Kit signaling inhibits the sphingomyelin-ceramide pathway through PLCgamma 1: implication in stem cell factor radioprotective effect
Blood,
July 30, 2002;
100(4):
1294 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, L. Liu, J. C. Tupper, D. D. Bannerman, R. K. Winn, S. M. Sebti, A. D. Hamilton, and J. M. Harlan
Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial Cells
J. Biol. Chem.,
May 3, 2002;
277(18):
15309 - 15316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nagasawa, A. Cremesti, R. Kolesnick, Z. Fuks, and J. B. Little
Involvement of Membrane Signaling in the Bystander Effect in Irradiated Cells
Cancer Res.,
May 1, 2002;
62(9):
2531 - 2534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ganss, E. Ryschich, E. Klar, B. Arnold, and G. J. Hammerling
Combination of T-Cell Therapy and Trigger of Inflammation Induces Remodeling of the Vasculature and Tumor Eradication
Cancer Res.,
March 1, 2002;
62(5):
1462 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ozen, D. Giri, F. Ropiquet, A. Mansukhani, and M. Ittmann
Role of Fibroblast Growth Factor Receptor Signaling in Prostate Cancer Cell Survival
J Natl Cancer Inst,
December 5, 2001;
93(23):
1783 - 1790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre
Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology
Circ. Res.,
November 23, 2001;
89(11):
957 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo, and R. Kolesnick
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
Science,
July 13, 2001;
293(5528):
293 - 297.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H.-P. DEIGNER, R. CLAUS, G. A. BONATERRA, C. GEHRKE, N. BIBAK, M. BLAESS, M. CANTZ, J. METZ, and R. KINSCHERF
Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis
FASEB J,
March 1, 2001;
15(3):
807 - 814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Selzner, A. Bielawska, M. A. Morse, H. A. Rüdiger, D. Sindram, Y. A. Hannun, and P.-A. Clavien
Induction of Apoptotic Cell Death and Prevention of Tumor Growth by Ceramide Analogues in Metastatic Human Colon Cancer
Cancer Res.,
February 1, 2001;
61(3):
1233 - 1240.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Lozano, S. Menendez, A. Morales, D. Ehleiter, W.-C. Liao, R. Wagman, A. Haimovitz-Friedman, Z. Fuks, and R. Kolesnick
Cell Autonomous Apoptosis Defects in Acid Sphingomyelinase Knockout Fibroblasts
J. Biol. Chem.,
January 5, 2001;
276(1):
442 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick
Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes
J. Biol. Chem.,
March 9, 2001;
276(11):
8297 - 8305.
[Abstract]
[Full Text]
[PDF]
|
 |
|